---

期 刊 ：中国中药杂志 2007年 32卷 09期 页码：850.

关键词：心脉通胶囊；急性冠脉综合征；基质金属蛋白酶-9；高敏C反应蛋白；

Keywords:Xinmaitong capsule, ACS, matrix metalloproteinases-9, high sensitive C-reactive protein,

摘 要 ：目的：探讨心脉通胶囊对急性冠脉综合征(ACS)患者抑制细胞外基质降解,减少炎症反应,稳定斑块的作用。方法：采用随机对照方法将ACS患者分为治疗组(对照组基础上加用心脉通胶囊n=31)、对照组(n=32),于治疗前后分别测定血清MMP-9与hs-CRP水平。结果：对照组MMP-9较治疗前有所下降但无统计学意义,而hs-CRP水平治疗后有显著性下降。治疗组MMP-9与hs-CRP水平均较治疗前明显改善,并明显优于对照组(P<0.05)。ACS患者MMP-9与hs-CRP水平呈正相关,而MMP-9,hs-CRP与血脂无相关。结论：心脉通胶囊可能通过抑制MMP-9,降低hs-CRP,而减少细胞外基质降解,减轻炎症反应达到稳定斑块的作用。

Abstract:Objective: To observe the influence of Xinmaitong capsule (XMT) on serum matrix metalloproteinases-9, high sensitive C-reactive protein levels in patients with acute coronary syndrome. Method: 63 cases were divided by randomized, contrastive assigned to XMT group (n=31) and control group (n=32). The serum levels of MMP-9 and hs-CRP before and after treatment in 12 weeks were detected. Result: After treatment, the serum levels of MMP-9 in control group had no changed and the levels of hs-CRP reduced. The serum levels of MMP-9 and hs-CRP in XMT group had significantly decreased. The serum levels of MMP-9 and hs-CRP had positive correlation, but had no correlation to levels of serum lipids. Conclusion: XMT decreased breakdown of matrix collagen, and inflammatory reaction in the patients of ACS, which may have effect on plaque stabilization.

---